Unleashing Shareholder Influence: CUEN’s Game-Changing Proxy Vote Link Sparks a Call to Action!

Unleashing Shareholder Influence: CUEN’s Game-Changing Proxy Vote Link Sparks a Call to Action! Description: Cuentas, Inc.’s announced shareholders are now able to cast their proxy votes in advance of the Annual Meeting of Shareholders scheduled for December 20, 2023, at 10 am (EDT). Launches electronic voting site and printed material distribution. MIAMI BEACH, FL, Dec….

Read More

Breaking Down the Numbers: Elevai Labs Inc. Reveals Financial Results for Q3 of 2023

Company Records Record Quarterly Revenues NEWPORT BEACH, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) — Elevai Labs Inc. (NASDAQ: ELAB), a medical aesthetic company specializing in physician-dispensed skincare, today reported financial results for its Q3 2023 fiscal quarter, ended September 30, 2023. Exciting News for Elevai Labs Inc It’s always a cause for celebration when a…

Read More

Unleashing the Crypto Bears: CoinShares Weekly Report Reveals Surprising Market Trends

CoinShares Report: Altcoins Shine as Investors Diversify Crypto Portfolios Introduction The latest CoinShares’ Digital Asset Fund Flows Weekly Report, published on December 11, sheds light on the evolving investment strategies of institutional investors in the cryptocurrency market. The report highlights a noticeable shift towards altcoins as investors seek to diversify their crypto portfolios. Key Findings…

Read More

Concerns for the Health of Nobel Laureate Mohammadi: A Heartfelt Reflection from Her Children

The Long-term Effects of Hunger Strike on Imprisoned Human Rights Activist Narges Mohammadi The Plight of Narges Mohammadi The children of imprisoned Iranian human rights activist and Nobel Peace Prize laureate Narges Mohammadi said Monday they were “extremely worried” about her health after she undertook a hunger strike in a Tehran prison. Mohammadi, who has…

Read More

Unlocking Profit Potential: Axsome Therapeutics Unveils Promising Data and Analysis of Auvelity for Major Depressive Disorder at ACNP 2023 Annual Meeting

Axsome Therapeutics Presents New Data and Post-Hoc Analyses of Auvelity® in Patients with Major Depressive Disorder New data on Auvelity’s impact on quality of life, measured by the Q-LES-Q-SF, in patients who had received at least one prior treatment during their current depressive episode Data on Auvelity exploring reduction of depressive symptoms regardless of a…

Read More